|
VEGF
Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth. Defects in VEGFA are a cause of susceptibility to microvascular complications of diabetes type 1 (MVCD1). These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Belongs to the PDGF/VEGF growth factor family. 13 isoforms of the human protein are produced by alternative promoter. Note: This description may include information from UniProtKB.
|
| Protein type: Motility/polarity/chemotaxis; Secreted, signal peptide; Cytokine; Secreted |
|
Cellular Component: extracellular space; cell surface; membrane; cytoplasm; extracellular region; plasma membrane; basement membrane; secretory granule
|
|
Molecular Function: heparin binding; protein homodimerization activity; growth factor activity; cytokine activity; platelet-derived growth factor receptor binding; vascular endothelial growth factor receptor 1 binding; cell surface binding; receptor agonist activity; vascular endothelial growth factor receptor binding; vascular endothelial growth factor receptor 2 binding; protein heterodimerization activity; fibronectin binding; chemoattractant activity
|
|
Biological Process: heart morphogenesis; positive regulation of cell adhesion; positive regulation of positive chemotaxis; macrophage differentiation; multicellular organismal development; positive regulation of receptor internalization; cell maturation; basophil chemotaxis; positive regulation of MAP kinase activity; regulation of cell shape; positive chemotaxis; positive regulation of mesenchymal cell proliferation; mesoderm development; kidney development; positive regulation of neuroblast proliferation; nervous system development; T-helper 1 type immune response; monocyte differentiation; positive regulation of signal transduction; mRNA stabilization; positive regulation of blood vessel endothelial cell migration; activation of CREB transcription factor; positive regulation of protein amino acid autophosphorylation; positive regulation of vascular permeability; patterning of blood vessels; regulation of transcription from RNA polymerase II promoter; positive regulation of peptidyl-tyrosine phosphorylation; eye photoreceptor cell development; positive regulation of angiogenesis; camera-type eye morphogenesis; branching morphogenesis of a tube; cell migration during sprouting angiogenesis; cardiac muscle fiber development; positive regulation of cell division; activation of protein kinase activity; blood vessel morphogenesis; positive regulation of endothelial cell proliferation; positive regulation of transcription from RNA polymerase II promoter; surfactant homeostasis; alveolus development; positive regulation of epithelial cell proliferation; negative regulation of apoptosis; lactation; post-embryonic camera-type eye development; behavior; positive regulation of smooth muscle cell proliferation; negative regulation of caspase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of vascular endothelial growth factor receptor signaling pathway; induction of positive chemotaxis; positive regulation of focal adhesion formation; vasculature development; ovarian follicle development; epithelial cell differentiation; positive regulation of cell proliferation; angiogenesis; cell differentiation; negative regulation of bone resorption; blood vessel development; cell migration; in utero embryonic development; positive regulation of cell motility; positive regulation of peptidyl-serine phosphorylation; cell proliferation; positive regulation of protein complex assembly; response to hypoxia; artery morphogenesis; blood vessel remodeling; positive regulation of protein amino acid phosphorylation; vascular endothelial growth factor receptor signaling pathway; growth; positive regulation of cell migration; lung development
|
|
Reference #:
NP_001020421 (RefSeq)
|
| Alt. Names/Synonyms: OTTMUSP00000017463; OTTMUSP00000017464; OTTMUSP00000022243; Vascular endothelial growth factor A; Vascular permeability factor; Vegf; VEGF-A; Vegf120; Vegf164; Vegf188; Vegfa; VPF |
| Gene Symbols: Vegfa |
|
Molecular weight: 43,131 Da
|
|
Basal Isoelectric point: 9.27
Predict pI for various phosphorylation states
|
|
CST Pathways:
Angiogenesis
|
